Nexgel, Inc. (NXGL): Operating Income
-$3.35M
Year ended 2025-12-31
-$5.40M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.35M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$3.55M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$3.48M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$3.35M | n/m | 2024-04-10, From 2022-01-01 |
| 2021-12-31 | -$2.57M | n/m | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | -$2.26M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$1.92M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$1.89M | n/a | 2020-04-03, From 2018-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Nexgel, Inc. (NXGL) | 2025-12-31 | -$3.35M | n/m |
| Medinotec Inc. (MDNC) | 2026-02-28 | $1.09M | -65.7% |
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | -$4.23M | n/m |
| InspireMD, Inc. (NSPR) | 2025-12-31 | -$49.61M | n/m |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$30.16M | n/m |
| Biotricity Inc. (BTCY) | 2026-03-31 | $1.69M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | -$41.25M | n/m |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | -$29.04M | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$19.89M | n/m |
Compare NXGL, MDNC, NMTC, NSPR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗